Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute in Boston, Massachusetts, United States is listed as a site for 3,382 registered clinical trials, 1164 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 3,382
Ongoing 1,164

This page covers the site record Dana-Farber Cancer Institute in Boston, Massachusetts, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Dana-Farber Cancer Institute, also sponsors trials.

Get the Dana-Farber Cancer Institute report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 3,382 trials counted.

  • Phase 1 808 trials
  • Phase 1/2 428 trials
  • Phase 2 1,171 trials
  • Phase 2/3 38 trials
  • Phase 3 434 trials
  • Phase 4 18 trials
  • Not applicable 305 trials
  • Observational 154 trials
  • Expanded access 25 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 1,170 trials
  • Completed 1,646 trials
  • Terminated 487 trials
  • Other 79 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access, Unknown)

Top of scale: 206

1993: 1 trials (Phase 2 1) 1994: 5 trials (Phase 3 4, Phase 2 1) 1995: 6 trials (Observational 1, Phase 3 2, Phase 2 1, Phase 1 2) 1996: 10 trials (Phase 3 5, Phase 2 3, Phase 1 2) 1997: 19 trials (Observational 1, Not applicable 1, Phase 3 6, Phase 2 5, Phase 1/2 2, Phase 1 4) 1998: 36 trials (Observational 3, Not applicable 1, Phase 3 5, Phase 2 18, Phase 1/2 3, Phase 1 6) 1999: 31 trials (Observational 4, Phase 3 4, Phase 2 11, Phase 1/2 2, Phase 1 10) 2000: 53 trials (Observational 2, Not applicable 1, Phase 3 12, Phase 2 23, Phase 1/2 3, Phase 1 12) 2001: 38 trials (Observational 3, Not applicable 4, Phase 3 5, Phase 2 19, Phase 1/2 1, Phase 1 6) 2002: 28 trials (Observational 1, Not applicable 2, Phase 3 1, Phase 2/3 1, Phase 2 15, Phase 1/2 1, Phase 1 7) 2003: 43 trials (Observational 1, Not applicable 3, Phase 3 5, Phase 2 22, Phase 1/2 2, Phase 1 10) 2004: 62 trials (Observational 6, Not applicable 5, Phase 3 8, Phase 2/3 1, Phase 2 34, Phase 1/2 4, Phase 1 4) 2005: 58 trials (Observational 2, Not applicable 4, Phase 3 8, Phase 2/3 1, Phase 2 27, Phase 1/2 6, Phase 1 10) 2006: 98 trials (Observational 5, Not applicable 7, Phase 3 9, Phase 2 51, Phase 1/2 8, Phase 1 18) 2007: 102 trials (Other 1, Observational 5, Not applicable 3, Phase 3 14, Phase 2 42, Phase 1/2 9, Phase 1 28) 2008: 80 trials (Observational 7, Not applicable 6, Phase 3 8, Phase 2/3 1, Phase 2 27, Phase 1/2 11, Phase 1 20) 2009: 101 trials (Observational 9, Not applicable 2, Phase 3 15, Phase 2 40, Phase 1/2 12, Phase 1 23) 2010: 106 trials (Observational 6, Not applicable 5, Phase 4 1, Phase 3 14, Phase 2 45, Phase 1/2 17, Phase 1 18) 2011: 117 trials (Observational 10, Not applicable 5, Phase 3 13, Phase 2/3 1, Phase 2 46, Phase 1/2 11, Phase 1 31) 2012: 115 trials (Observational 5, Not applicable 7, Phase 3 14, Phase 2/3 1, Phase 2 51, Phase 1/2 12, Phase 1 25) 2013: 120 trials (Other 1, Observational 4, Not applicable 8, Phase 4 3, Phase 3 16, Phase 2/3 1, Phase 2 45, Phase 1/2 10, Phase 1 32) 2014: 131 trials (Observational 6, Not applicable 8, Phase 3 18, Phase 2/3 4, Phase 2 33, Phase 1/2 22, Phase 1 40) 2015: 168 trials (Observational 6, Not applicable 12, Phase 4 1, Phase 3 19, Phase 2/3 1, Phase 2 60, Phase 1/2 28, Phase 1 41) 2016: 160 trials (Observational 5, Not applicable 11, Phase 3 17, Phase 2/3 4, Phase 2 55, Phase 1/2 27, Phase 1 41) 2017: 206 trials (Observational 9, Not applicable 14, Phase 4 1, Phase 3 31, Phase 2 78, Phase 1/2 27, Phase 1 46) 2018: 205 trials (Observational 6, Not applicable 25, Phase 4 1, Phase 3 23, Phase 2 65, Phase 1/2 29, Phase 1 56) 2019: 186 trials (Observational 9, Not applicable 26, Phase 4 1, Phase 3 16, Phase 2/3 6, Phase 2 62, Phase 1/2 22, Phase 1 44) 2020: 174 trials (Observational 6, Not applicable 11, Phase 4 2, Phase 3 19, Phase 2/3 2, Phase 2 61, Phase 1/2 29, Phase 1 44) 2021: 169 trials (Observational 9, Not applicable 23, Phase 3 24, Phase 2/3 1, Phase 2 49, Phase 1/2 22, Phase 1 41) 2022: 161 trials (Observational 6, Not applicable 22, Phase 4 1, Phase 3 22, Phase 2/3 3, Phase 2 27, Phase 1/2 36, Phase 1 44) 2023: 149 trials (Observational 6, Not applicable 15, Phase 3 21, Phase 2/3 3, Phase 2 40, Phase 1/2 27, Phase 1 37) 2024: 165 trials (Observational 8, Not applicable 25, Phase 4 2, Phase 3 18, Phase 2/3 1, Phase 2 44, Phase 1/2 14, Phase 1 53) 2025: 141 trials (Observational 3, Not applicable 22, Phase 4 2, Phase 3 24, Phase 2/3 5, Phase 2 33, Phase 1/2 22, Phase 1 30)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 101
2025 141
2024 165
2023 149
2022 161
2021 169
2020 174
2019 186
2018 205
2017 206

Showing 10 of 34 years.

Start your 14-day trial Email me all 34 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 5 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 3,382 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 452 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 450 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF